Two examples are the insulin-sensitizing troglitazone, used to treat patients with type 2 diabetes, and the fibrate fenofibrate, mainly used in the treatment of hypertriglyceridemia [115,116]. This evidence concerns the gene INS and type 2 diabetes mellitus.